0001140361-16-069010.txt : 20160607
0001140361-16-069010.hdr.sgml : 20160607
20160607210734
ACCESSION NUMBER: 0001140361-16-069010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160606
FILED AS OF DATE: 20160607
DATE AS OF CHANGE: 20160607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOULWAN GEORGE A
CENTRAL INDEX KEY: 0001222197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 161702549
4
1
doc1.xml
FORM 4
X0306
4
2016-06-06
0
0001367644
Emergent BioSolutions Inc.
EBS
0001222197
JOULWAN GEORGE A
400 PROFESSIONAL DRIVE, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2016-06-06
4
S
0
4700
44.12
D
20785
D
Consists of vested restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.15.
/s/ Eric Burt, Attorney-in-fact
2016-06-07